BRPI0407714A - "exo-2r (+)-2-amino-7-azabiciclo[2.2.1]heptano-7-carboxilato de t-butila, intermediário, e processo para os preparar e isolar - Google Patents

"exo-2r (+)-2-amino-7-azabiciclo[2.2.1]heptano-7-carboxilato de t-butila, intermediário, e processo para os preparar e isolar

Info

Publication number
BRPI0407714A
BRPI0407714A BRPI0407714-8A BRPI0407714A BRPI0407714A BR PI0407714 A BRPI0407714 A BR PI0407714A BR PI0407714 A BRPI0407714 A BR PI0407714A BR PI0407714 A BRPI0407714 A BR PI0407714A
Authority
BR
Brazil
Prior art keywords
heptane
carboxylate
amino
preparing
exo
Prior art date
Application number
BRPI0407714-8A
Other languages
English (en)
Inventor
Tizah Evelyn Anjeh
Thomas Lee Fevig
Jon Philip Lawson
Daniel Patrick Walker
Donn Gregory Wishka
Original Assignee
Pharmacia & Up John Company Ll
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Up John Company Ll filed Critical Pharmacia & Up John Company Ll
Publication of BRPI0407714A publication Critical patent/BRPI0407714A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"EXO-2R(+)-2-AMINO-7-AZABICICLO¢2.2.1!HEPTANO -7-CARBOXILATO DE t-BUTILA, INTERMEDIáRIOS, E PROCESSO PARA OS PREPARAR E ISOLAR". A invenção presente diz respeito a exo-2R(+)-2-amino-7-azabiciclo ¢2.2.1!heptano-7-carboxilato de t-butila, intermediários, e processo para os preparar e isolar.
BRPI0407714-8A 2003-02-21 2004-02-09 "exo-2r (+)-2-amino-7-azabiciclo[2.2.1]heptano-7-carboxilato de t-butila, intermediário, e processo para os preparar e isolar BRPI0407714A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44924203P 2003-02-21 2003-02-21
PCT/IB2004/000430 WO2004074292A1 (en) 2003-02-21 2004-02-09 Exo-(t-butyl 2r(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them

Publications (1)

Publication Number Publication Date
BRPI0407714A true BRPI0407714A (pt) 2006-02-14

Family

ID=32908698

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407714-8A BRPI0407714A (pt) 2003-02-21 2004-02-09 "exo-2r (+)-2-amino-7-azabiciclo[2.2.1]heptano-7-carboxilato de t-butila, intermediário, e processo para os preparar e isolar

Country Status (7)

Country Link
US (1) US20060173063A1 (pt)
EP (1) EP1599483A1 (pt)
JP (1) JP2006518367A (pt)
BR (1) BRPI0407714A (pt)
CA (1) CA2516329A1 (pt)
MX (1) MXPA05008108A (pt)
WO (1) WO2004074292A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090247750A1 (en) * 2008-03-28 2009-10-01 Biocryst Pharmaceuticals, Inc. Process for preparing nucleoside analogs
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
AR099134A1 (es) * 2014-01-24 2016-06-29 Hoffmann La Roche Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
MX2017003254A (es) 2014-09-11 2017-10-12 Janssen Pharmaceutica Nv 2-azabiciclos sustituidos y su uso como moduladores de receptores de orexina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
EP0955301A3 (en) * 1998-04-27 2001-04-18 Pfizer Products Inc. 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
US20030105089A1 (en) * 2001-09-12 2003-06-05 Wishka Donn G. Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease

Also Published As

Publication number Publication date
MXPA05008108A (es) 2005-09-21
CA2516329A1 (en) 2004-09-02
US20060173063A1 (en) 2006-08-03
JP2006518367A (ja) 2006-08-10
EP1599483A1 (en) 2005-11-30
WO2004074292A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
WO2005107491A3 (en) Multi-lectin affinity chromatography and uses thereof
BR0308158B1 (pt) processo para o melhoramento de correntes brutas de hidrocarbonetos.
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
WO2006131928A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2007011363A3 (en) Binding domain fusion proteins
BRPI0414599A (pt) pirrol-indóis substituìdos
BRPI0517973B8 (pt) métodos para purificar o fsh recombinante
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
ITMI20021734A1 (it) Processo per la preparazione di perfluoropolieteri con terminali aldeidici, alcolici, amminici mediante riduzione catalitica.
BR0310115B1 (pt) processo para preparaÇço de dinitrilas de Ácido fenilmalânico.
TW200617011A (en) Process for preparing quinoline compounds and products obtained therefrom
BR0211391B1 (pt) processo para preparaÇço de 4-aminodifenilaminas.
BRPI0407714A (pt) "exo-2r (+)-2-amino-7-azabiciclo[2.2.1]heptano-7-carboxilato de t-butila, intermediário, e processo para os preparar e isolar
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
BRPI0500102A (pt) Adesivos contendo grupos de ortoésteres
MXPA03010498A (es) Proceso para la preparacion de imipenem.
BRPI0412721A (pt) processo para preparar bromidrato de eletriptano alfa-polimórfico
ITMI20022522A1 (it) Processo integrato per la preparazione di fenolo da benzene con riciclo dei sottoprodotti.
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
BRPI0408104A (pt) processo para a produção de tibolona
PT1252327E (pt) Processo para a separacao enzimatica de racematos de derivados de aminometilaril-ciclo-hexanol
WO2004047751A3 (en) Calcilytic compounds
TW200503991A (en) Hydrogenation of imine intermediates of sertraline with catalysts
WO2005017177A3 (en) Modulators of nod1 signaling
BRPI0411921A (pt) processo para preparar intermediários úteis para preparar determinadas hidroxilaminas de n-formila antibacterianas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired